NCT04955522

Brief Summary

In this study, we retrospectively analyzed the imaging data of spinal tumors to find out more imaging features of spinal tumors, in order to provide more accurate reference for the diagnosis of spinal tumors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
242

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 8, 2021

Completed
Last Updated

July 8, 2021

Status Verified

December 1, 2019

Enrollment Period

14 days

First QC Date

June 29, 2021

Last Update Submit

July 1, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • radiomics features

    1409 radiomics features can be extracted from the images. Objective to search for the radiomics index which is helpful to the diagnosis of tumor.

    2020.12.1-2020.12.25

Study Arms (2)

metastases

patients with spinal metastases

Diagnostic Test: radiomics

multiple myeloma

patients with spinal multiple myeloma

Interventions

radiomicsDIAGNOSTIC_TEST

Differential diagnosis of spinal myeloma and metastases by radiomics

metastases

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Spinal tumor patients in Peking University Third Hospital from January 2006 to October 2019

You may qualify if:

  • Complete and accurate clinical and pathological data are available;Imaging examination was performed in our hospital

You may not qualify if:

  • Patients with missing image data and unclear image

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, Beijing Municipality, 010, China

Location

MeSH Terms

Conditions

Bone Neoplasms

Interventions

Radiomics

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Huishu Yuan

    Peking University Third Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2021

First Posted

July 8, 2021

Study Start

December 1, 2019

Primary Completion

December 15, 2019

Study Completion

December 30, 2020

Last Updated

July 8, 2021

Record last verified: 2019-12

Locations